Search research articles
Contact Us
Filters
Showing results (31-40 of 75) with videos related to
Page
of 8
Sort By:
Clinical and Laboratory Haematology
|
November 14, 1997
An original method to study autoantibody specificity in haemoglobin stained eluates by the column agglutination techniques
F Fiorin, M R Cozzi, P Pradella, et al.
Toxicology and Applied Pharmacology
|
January 6, 2000
Phyllanthus orbicularis aqueous extract: cytotoxic, genotoxic, and antimutagenic effects in the CHO cell line
A Sànchez-Lamar, M Fiore, E Cundari, et al.
Journal of Chromatography
|
August 31, 1988
Chromatographic and cytogenetic analysis of in vivo metabolites of fluoranthene
C Polcaro, I Nicoletti, L Ossicini, et al.
Pituitary
|
January 15, 2002
Lanreotide 60 mg, a longer-acting somatostatin analog: tumor shrinkage and hormonal normalization in acromegaly
R Cozzi, M Barausse, M Sberna, et al.
Cell Biology and Toxicology
|
June 5, 2008
Levodopa therapy reduces DNA damage in peripheral blood cells of patients with Parkinson's disease
T Cornetta, S Palma, I Aprile, et al.
Mutation Research
|
June 1, 1986
An in vitro and in vivo study on mutagenic activity of fluoranthene: comparison between cytogenetic studies and HPLC analysis
F Palitti, R Cozzi, M Fiore, et al.
Journal of Endocrinological Investigation
|
January 20, 2024
Real-life data of Pasireotide LAR in acromegaly: a long-term follow-up
C Urbani, F Dassie, B Zampetti, et al.
The New England Journal of Medicine
|
September 12, 1985
Low doses of dopamine agonists in the long-term treatment of macroprolactinomas
A Liuzzi, D Dallabonzana, G Oppizzi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 1, 1986
Serum type III procollagen propeptide levels in acromegalic patients
G G Verde, I Santi, P Chiodini, et al.
Mutation Research
|
December 1, 1995
Persistence of increased levels of ribosomal gene activity in CHO-K1 cells treated in vitro with demethylating agents
P Giancotti, C Grappelli, I Poggesi, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 75) with videos related to
Sort By:
Page
of 8
Clinical and Laboratory Haematology
|
November 14, 1997
An original method to study autoantibody specificity in haemoglobin stained eluates by the column agglutination techniques
F Fiorin, M R Cozzi, P Pradella, et al.
Toxicology and Applied Pharmacology
|
January 6, 2000
Phyllanthus orbicularis aqueous extract: cytotoxic, genotoxic, and antimutagenic effects in the CHO cell line
A Sànchez-Lamar, M Fiore, E Cundari, et al.
Journal of Chromatography
|
August 31, 1988
Chromatographic and cytogenetic analysis of in vivo metabolites of fluoranthene
C Polcaro, I Nicoletti, L Ossicini, et al.
Pituitary
|
January 15, 2002
Lanreotide 60 mg, a longer-acting somatostatin analog: tumor shrinkage and hormonal normalization in acromegaly
R Cozzi, M Barausse, M Sberna, et al.
Cell Biology and Toxicology
|
June 5, 2008
Levodopa therapy reduces DNA damage in peripheral blood cells of patients with Parkinson's disease
T Cornetta, S Palma, I Aprile, et al.
Mutation Research
|
June 1, 1986
An in vitro and in vivo study on mutagenic activity of fluoranthene: comparison between cytogenetic studies and HPLC analysis
F Palitti, R Cozzi, M Fiore, et al.
Journal of Endocrinological Investigation
|
January 20, 2024
Real-life data of Pasireotide LAR in acromegaly: a long-term follow-up
C Urbani, F Dassie, B Zampetti, et al.
The New England Journal of Medicine
|
September 12, 1985
Low doses of dopamine agonists in the long-term treatment of macroprolactinomas
A Liuzzi, D Dallabonzana, G Oppizzi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 1, 1986
Serum type III procollagen propeptide levels in acromegalic patients
G G Verde, I Santi, P Chiodini, et al.
Mutation Research
|
December 1, 1995
Persistence of increased levels of ribosomal gene activity in CHO-K1 cells treated in vitro with demethylating agents
P Giancotti, C Grappelli, I Poggesi, et al.
Page
of 8